BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging & Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250704T133000
DTEND;TZID=Europe/Vienna:20250704T143000
DTSTAMP:20260419T065151
CREATED:20241017T075136Z
LAST-MODIFIED:20250630T084441Z
UID:1917-1751635800-1751639400@esmit.eanm.org
SUMMARY:Alpha Emitters – The Roadmap of the Big Ones!
DESCRIPTION:The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes\, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters\, such as their high linear energy transfer and short path length\, which allow for precise tumor cell killing with minimal damage to surrounding tissue. The seminar will also address key challenges\, including limited availability of suitable alpha-emitting radionuclides\, complex radiochemistry\, and safety concerns during production and handling. Emphasis will be placed on production routes\, chelation strategies\, and conjugation chemistry that enable targeted delivery to cancer cells. Finally\, the session will critically evaluate the therapeutic potential and limitations of alpha therapy\, highlighting areas for future research and clinical translation. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nParticipants will gain understanding of the advantages of alpha-emitters over beta emitter\n\n\n\nParticipants will be able to describe and explain challenges arising from applications of alpha-emitters\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nRadiochemist\, Radiopharmacists\, nuclear physicians with a research profile\, medicinal chemistry researchers\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nMatthias HerthSpeaker \n\n\n\n\n\nFilipe ElvasSpeaker \n\n\n\n\n\nDana NiculaeModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/alpha-emitters-the-roadmap-of-the-big-ones/
CATEGORIES:Live Webinars,Radiopharmaceuticals
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250627T133000
DTEND;TZID=Europe/Vienna:20250627T143000
DTSTAMP:20260419T065151
CREATED:20241017T080743Z
LAST-MODIFIED:20250624T092530Z
UID:1932-1751031000-1751034600@esmit.eanm.org
SUMMARY:Extravascular Administration in Diagnostic and Therapeutic Nuclear Medicine
DESCRIPTION:In nuclear medicine\, diagnostic as well as therapeutic\, radiopharmaceuticals are administered via an intravenous injection\, in a majority of the procedures in a blood vessel at the crook of the arm or on the back of the hand. Occasionally\, the injection fails\, which results in the radiopharmaceutical ending up extravascularly. The consequence of this may be a locally high radiation dose at the injection site\, in some situations high enough to cause severe tissue effects on the patient. Thus\, it is important to recognize the problem and identify the cause in order to decrease the risk. Furthermore\, the management of the situation after such an extravasation must be dealt with thoroughly and this has been the subject of lively debate in recent years. The parameters that have an impact on the radiation dose are among other things\, the physical properties of the radionuclide\, as well as the activity and volume of the radioactive substance retained in the surroundings of the blood vessel. In the case when most of the administered activity ends up extravascular\, the quality of the diagnostic procedure or the effect of the treatment are negatively affected\, which must be addressed. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\nThe aim of this webinar is to highlight the risk and consequences of extravascular administration of radiopharmaceuticals as well as the management of the situation after an extravasation. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nPhysicists\, Physicians\, Technologists\, Nurses \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSiria MediciSpeaker \n\n\n\n\n\nJochem van der Pol Speaker \n\n\n\n\n\nSigrid Leide SvegbornModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/extravascular-administration-in-diagnostic-and-therapeutic-nuclear-medicine/
CATEGORIES:Instrumentation, Technology, Science,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250613T133000
DTEND;TZID=Europe/Vienna:20250613T143000
DTSTAMP:20260419T065151
CREATED:20241017T081027Z
LAST-MODIFIED:20250605T095541Z
UID:1934-1749821400-1749825000@esmit.eanm.org
SUMMARY:Cardiac Amyloidosis Imaging: Do We Need Quantification?
DESCRIPTION:This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore\, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context\, the relevance of quantification to characterize disease and how to assess reliably the effects of therapy are presented. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo gain a insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nTo learn the possibilities of quantification of planar and SPECT studies in amyloidosis\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear physicians\, cardiologists\, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics and quantification\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nFederico CaobelliSpeaker \n\n\n\n\n\nIan ArmstrongSpeaker \n\n\n\n\n\nCarmela NappiModerator \n\n\n\n\n\nStephan NekollaModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiac-amyloidosis-imaging-do-we-need-quantification/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250509T133000
DTEND;TZID=Europe/Vienna:20250509T143000
DTSTAMP:20260419T065151
CREATED:20241017T080513Z
LAST-MODIFIED:20250505T100056Z
UID:1930-1746797400-1746801000@esmit.eanm.org
SUMMARY:Introducing Dosimetry in the Clinical Setting
DESCRIPTION:This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nThe aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear medicine clinicians and medical physicists \n\n\n\n \n\n\n\nSuggested Readings\n\n\n\n \n\n\n\n“EANM enabling guide: how to improve the accessibility of clinical dosimetry.” Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry \n\n\n\n\nClick Here\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nJonathan GearSpeaker \n\n\n\n\n\nPablo Mínguez GabiñaSpeaker \n\n\n\n\n\nEivor HernesSpeaker \n\n\n\n\n\nSilvano GnesinModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/introducing-dosimetry-in-the-clinical-setting/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250425T133000
DTEND;TZID=Europe/Vienna:20250425T143000
DTSTAMP:20260419T065151
CREATED:20241017T081307Z
LAST-MODIFIED:20250214T105155Z
UID:1936-1745587800-1745591400@esmit.eanm.org
SUMMARY:Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging (pre-recorded)
DESCRIPTION:more information coming soon \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/highlights-of-focus-meeting-6-shaping-the-future-of-breast-cancer-care-with-molecular-imaging-prerecorded/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250404T133000
DTEND;TZID=Europe/Vienna:20250404T143000
DTSTAMP:20260419T065151
CREATED:20241017T080415Z
LAST-MODIFIED:20250326T095143Z
UID:1928-1743773400-1743777000@esmit.eanm.org
SUMMARY:Radioiodine-Refractory Thyroid Cancer - Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?
DESCRIPTION:This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer\, highlighting recent clinical trials\, molecular targeting techniques\, and potential promising combination therapies. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo evaluate the current definition of radiorefractory thyroid cancer and identify its limitations in clinical practice\n\n\n\nTo learn new insights for radiorefractory thyroid cancer definition and their potential impact on treatment decisions\n\n\n\nTo learn current evidence-based redifferentiation strategies for restoring iodine avidity in radiorefractory thyroid cancer\n\n\n\nTo improve knowledge of redifferentiation mechanisms to develop personalized treatment plans for patients with radiorefractory thyroid cancer\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine physicians\, Endocrinologist\, Oncologist \n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nPetra PetranovicSpeaker \n\n\n\n\n\nMichael KreisslSpeaker \n\n\n\n\n\nLuca GiovanellaModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/radioiodine-refractory-thyroid-cancer-is-it-time-to-change-the-definition-in-the-light-of-novel-redifferentiation-therapies/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250328T133000
DTEND;TZID=Europe/Vienna:20250328T143000
DTSTAMP:20260419T065151
CREATED:20241017T080209Z
LAST-MODIFIED:20250312T095042Z
UID:1926-1743168600-1743172200@esmit.eanm.org
SUMMARY:Theranostic Training: Practical and Methodological Concepts
DESCRIPTION:This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes\, and how we can leverage these strengths in practice. \n\n\n\nPlease note that the webinar will be recorded\, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform\, under the webinar title. A handout of the presentation materials will also be available on the platform. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnroll in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nAttendees will understand the concept of theranostics and its significance in modern healthcare.\n\n\n\nAttendees will explore the foundational technologies behind theranostics and learn how departments can be organized to integrate theranostic procedures.\n\n\n\nAttendees will gain insights into the perspectives of physicians and technologists on theranostics and how these disciplines collaborate to deliver optimal patient outcomes.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nTechnologists\, Nurses\, Physicists\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nRiccardo LaudicellaSpeaker \n\n\n\n\n\nDaniela FonsecaSpeaker \n\n\n\n\n\nAngelo CardosoModerator \n\n\n\n\n\nConrad-Amadeus VoltinModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/theranostic-training-for-technologists/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250307T133000
DTEND;TZID=Europe/Vienna:20250307T143000
DTSTAMP:20260419T065151
CREATED:20241017T080042Z
LAST-MODIFIED:20250224T082009Z
UID:1924-1741354200-1741357800@esmit.eanm.org
SUMMARY:Advantages of Long-Axial Field-of-View PET in Inflammation and Infection Imaging
DESCRIPTION:Long axial field of view (LAFOV) PET/CT is the latest development in PET instrumentation. This webinar will provide an overview of the clinical opportunities and applications of LAFOV PET in inflammation and infection imaging. \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\n\nAttendees will be able to describe the main advantages of LAFOV PET in patients with inflammatory and infectious disorders.\n\n\n\nAttendees will be able to understand how the increased sensitivity of LAFOV PET/CT allows for faster scanning and/or an important reduction in injected activity\, and how it also enables dynamic whole-body PET imaging\, studying molecular interactions between organ systems and even delayed imaging.\n\n\n\nAttendees will be able to see that ultrafast imaging can facilitate imaging of new patient groups such as critically ill patients\, patients admitted to intensive care with persistent infection or children without sedation.\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\n\nNuclear Medicine Physicians\, Residents\, Technologists\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n\n\nJoyce van SluisSpeaker \n\n\n\n\n\nLars GormsenSpeaker \n\n\n\n\n\nAndor GlaudemansSpeaker \n\n\n\n\n\nOliver GheysensModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/advantages-of-long-axial-field-of-view-pet-in-inflammation-and-infection-imaging/
CATEGORIES:Instrumentation, Technology, Science,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250221T133000
DTEND;TZID=Europe/Vienna:20250221T143000
DTSTAMP:20260419T065151
CREATED:20241017T075932Z
LAST-MODIFIED:20250217T121048Z
UID:1922-1740144600-1740148200@esmit.eanm.org
SUMMARY:Surgery in Neuroendocrine Neoplasms (NENs)
DESCRIPTION:Neuroendocrine tumours (NETs) are a rare but clinically significant group of malignancies arising from neuroendocrine cells\, often presenting in the gastrointestinal tract or lungs. While NETs account for a small fraction of overall cancer cases\, their incidence is steadily rising. Radioguided surgery has emerged as a highly effective approach for treating NETs\, particularly in cases of primary tumours or oligometastatic disease\, where nuclear medicine imaging precisely localizes the lesions and surgical resection is feasible. \n\n\n\nThis session will explore the current landscape of radioguided surgery\, with a specific focus onneuroendocrine tumour applications. We will begin by reviewing the latest tracers and instrumentation employed in radioguided procedures\, discussing their mechanisms\, advantages\, and limitations. Following this\, we will delve into the clinical integration of these tracers and devices\, examining their role in the routine surgical workflow for NETs. By highlighting the practical implications and clinical outcomes\, this session aims to provide attendees with actionable insights into advancing care for patients with neuroendocrine tumours. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nAttendees will be able to describe the latest advancements in radiotracers and surgical instrumentation for radioguided neuroendocrine tumour surgery\, including their mechanisms of action and clinical benefits. \n\n\n\nAttendees will be able to evaluate the indications for radioguided surgery in neuroendocrine tumours\, such as primary tumours and oligometastatic disease\, based on pre-operative nuclear medicine imaging. \n\n\n\nAttendees will be able to outline the steps required to integrate novel radiotracers and devices into the clinical workflow\, from surgical planning to intraoperative application\, with a focus on improving patient outcomes.\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nSurgical oncologists\, nuclear medical physicians\, medical physicists\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nThomas WendlerModerator \n\n\n\n\n\nPedro Fragoso Costa Speaker \n\n\n\n\n\nJohn Orozco CortesSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/surgery-in-neuroendocrine-neoplasms-nens/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250207T133000
DTEND;TZID=Europe/Vienna:20250207T143000
DTSTAMP:20260419T065151
CREATED:20241017T075631Z
LAST-MODIFIED:20250203T100308Z
UID:1920-1738935000-1738938600@esmit.eanm.org
SUMMARY:Bone Scan Beyond Oncological Disease
DESCRIPTION:The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings\, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights the diagnostic enhancement of early-phase imaging for inflammatory conditions\, pain assessment\, and soft-tissue evaluation. \n\n\n\nNew treatment options for cardiac amyloidosis are increasing interest in early diagnosis of the disease. DPD scan is an excellent and non-invasive diagnostic modality in this diagnosis\, but detailed local\, whole body and SPECT/CT including calculation of different ratios are necessary for an accurate diagnosis. The presentation showed the performance of the examination\, clinical and medical letter examples.  \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinSpeakerArlon\, Belgium \n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bone-scan-beyond-oncological-disease/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241206T133000
DTEND;TZID=Europe/Vienna:20241206T143000
DTSTAMP:20260419T065151
CREATED:20240213T193126Z
LAST-MODIFIED:20241203T102334Z
UID:1300-1733491800-1733495400@esmit.eanm.org
SUMMARY:Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
DESCRIPTION:With the arrival of new therapeutic tracers\, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy\, medical treatment\, chemotherapy). \n\n\n\nLearning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities and limitations of alpha and beta therapy in metastatic bone pain treatment \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinModeratorArlon\, Belgium \n\n\n\n\n\n\n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\nTatiana LouroSpeakerLisbon\, Portugal \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/treatment-of-metastatic-bone-pain-using-bone-seeking-agents-msk/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241202T100000
DTEND;TZID=Europe/Vienna:20241202T110000
DTSTAMP:20260419T065151
CREATED:20240702T080051Z
LAST-MODIFIED:20241119T122958Z
UID:1737-1733133600-1733137200@esmit.eanm.org
SUMMARY:Japanese vs. European View on Amyloid Imaging and Therapy (in collaboration with JSNM)
DESCRIPTION:The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However\, due to differences in clinical processes and insurance systems in each country\, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe\, CSF diagnosis is often performed first and amyloid PET is performed in selected patients. In Japan\, only either CSF diagnosis or amyloid PET is covered by public insurance\, so there is a trend toward performing the more expensive PET first. The use of amyloid PET in the setting of anti-AB therapy monitoring\, and its exact positioning in the biomarkers  flow-chart is not yet clearly defined. This webinar will present recent findings on the usefulness of amyloid PET and the differences in actual use between Europe and Japan. \n\n\n\nLearning Objectives: tba \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDonatienne Van WeehaegheModerator \n\n\n\n\n\n\n\n\n\n\n\nProf. Dr. med. Dr. biol. hum. Matthias Brendel\, MHBASpeakerDepartment leadBoard certified Nuclear Medicine physician Research lead for neurodegenerative disorders LMU Klinikum   Department of Nuclear MedicineUniversity Hospital of Munich \n\n\n\n\n\nDr. Kenji IshiiSpeakerDirectorDiagnostic Neuroimaging ResearchTokyo Metropolitan Institute for Geriatrics and GerontologyTokyo\, Japan \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/japanese-vs-european-view-on-amyloid-imaging-and-therapy-in-collaboration-with-jsnm/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241122T133000
DTEND;TZID=Europe/Vienna:20241122T143000
DTSTAMP:20260419T065151
CREATED:20240213T192901Z
LAST-MODIFIED:20241004T123239Z
UID:1298-1732282200-1732285800@esmit.eanm.org
SUMMARY:Challenges of Zr89 Imaging
DESCRIPTION:While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging\, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies\, the radionuclide is non-ideal imaging qualities mostly due to its low dosage\, and also brings with it radiation safety challenges. This webinar will present both sides of Zr-89 imaging\, the clinically relevant opportunities for the radionuclide\, and the quantification challenges\, handling and the safety aspects of Zr-89. \n\n\n\nLearning Objectives: The aim of this webinar is to show the potential and the challenges of Zr-89 imaging. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nFloris H.P. van VeldenModeratorLeiden\, Netherlands \n\n\n\n\n\nErik AarntzenSpeakerNijmegen\, Netherlands \n\n\n\n\n\nMarc C. HuismanSpeakerAmsterdam\, Netherlands \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/challenges-of-zr89-imaging/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241108T133000
DTEND;TZID=Europe/Vienna:20241108T143000
DTSTAMP:20260419T065151
CREATED:20240213T192553Z
LAST-MODIFIED:20240723T085928Z
UID:1296-1731072600-1731076200@esmit.eanm.org
SUMMARY:Artificial Intelligence in Dosimetry
DESCRIPTION:The rapid development in machine learning has generated new artificial intelligence (AI) based methods for improving dosimetry within nuclear medicine. This webinar will present the current status of AI within the dosimetry workflow for targeted radionuclide therapy. First\, AI methods for reducing SPECT acquisition times\, noise reduction and scatter correction will be covered. Thereafter\, AI methods for organ segmentation and voxel-based dosimetry\, together with AI methods for pre-therapeutically dosimetry estimate will be highlighted. \n\n\n\nLearning Objectives: The aim of this webinar is to understand the basics of AI methodologies used for dosimetry and receive knowledge about the current status of AI applications within dosimetry for targeted radionuclide therapies. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nPeter BernhardtModeratorGöteborg\, Sweden \n\n\n\n\n\n\n\n\n\n\n\nYuni Dewaraja  SpeakerMichigan\, USA \n\n\n\n\n\nJohannes Tran-GiaSpeakerWürzburg\, Germany \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/artificial-intelligence-in-dosimetry/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240920T133000
DTEND;TZID=Europe/Vienna:20240920T143000
DTSTAMP:20260419T065151
CREATED:20240213T192107Z
LAST-MODIFIED:20240731T083213Z
UID:1294-1726839000-1726842600@esmit.eanm.org
SUMMARY:Paediatric Nuclear Medicine in Nephro-Urology
DESCRIPTION:The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology\, with particular attention to the choice of the radiotracer\, the correct patient preparation\, and the acquisition protocol. Some typical cases will show the main points of image processing and results visualization. The clinical part will deal with hydronephrosis and hydroureteronephrosis\, spacing from typical pelvicureteral junction obstruction to obstructive megaureter\, and some complex malformations\, such as duplex kidneys. The selected cases will pinpoint the critical clues used in interpreting and reporting the scintigraphic studies and the integration of scintigraphic data with other imaging modalities (ultrasounds\, MRI\, etc.) in evaluating paediatric nephrourology patients. \n\n\n\nLearning Objectives: The aim of this course is to review the methodology and the main indications for scintigraphic studies in paediatric nephro-urology\, taking into accounts the more relevant and recent international guidelines and offering various examples taken from the current clinical practice. \n\n\n\nSuggested Readings:1. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children2. EANM procedural recommendations for managing the paediatric patient diagnostic nuclear medicine \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDiego CecchinModeratorPadua\, Italy \n\n\n\n\n\nPietro ZucchettaSpeakerPadua\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/paediatric-nuclear-medicine-in-nephro-urology/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240906T133000
DTEND;TZID=Europe/Vienna:20240906T143000
DTSTAMP:20260419T065151
CREATED:20240213T191555Z
LAST-MODIFIED:20240710T090914Z
UID:1291-1725629400-1725633000@esmit.eanm.org
SUMMARY:FDG-PET/CT in Breast Cancer
DESCRIPTION:Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality\, therefore being a major concern. 2-[18F]FDG PET/CT is commonly used in the clinical management of patients with breast cancer\, with significant impact on clinical management. Currently\, there is robust evidence supporting the usefulness of 2-[18F]FDG PET/CT in the initial staging of patients with locally advanced and metastatic breast cancer\, in the early assessment of treatment response and in the early detection of recurrence. The first presentation of this webinar will summarize the recently published “Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer” which was endorsed by other relevant societies in the subject of breast cancer (ACR\, ESSO\, ESTRO\, EUSOBI/ESR\, and EUSOMA). Updated information to support the recommendations to perform 2-[18F]FDG PET/CT in no special type breast cancer in different clinical settings will be provided. Despite no special type breast cancer presenting high 2-[18F]FDG avidity\, other breast cancer subtypes seem to be better evaluated with other PET radiopharmaceuticals. Therefore\, the second presentation will address the potential role of [18F]FES\, [89Zr]Trastuzumab\, [18F]Sodium fluoride (NaF)\, [18F]Fluciclovine (FACBC)\, [89Zr]Pembrolizumab and FAPI-ligands in breast cancer. During this webinar we want to brainstorm about the role of PET/CT in the different subtypes and clinical scenarios of patients with breast cancer. The webinar will be enriched by interactive clinical case discussion\, aiming to resemble the challenges found in daily clinical practice. \n\n\n\nLearning Objectives:  \n\n\n\n\nGeneral aspects to avoid false positive and false negative findings on 2-[18F]FDG PET/CT.\n\n\n\nDiagnostic accuracy of 2-[18F]FDG PET/CT compared to conventional imaging modalities.\n\n\n\nRecommendations for performing 2-[18F]FDG PET/CT in the initial staging\, in assessing response to therapy and in assessing recurrence.\n\n\n\nAppropriate PET radiopharmaceuticals to better address each breast cancer subtype.\n\n\n\nSpecific characteristics\, physiological biodistribution\, advantages and disadvantages of PET radiopharmaceuticals used in breast cancer beyond 2-[18F]FDG.\n\n\n\nGeneral interpretation criteria to optimize the information provided in the final PET/CT report.\n\n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nLioe-Fee de Geus-OeiModeratorLeiden\, Netherlands \n\n\n\n\n\nSofia VazSpeakerLisbon\, Portugal \n\n\n\n\n\nLidija AntunovicSpeakerMilan\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fdg-pet-ct-in-breast-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240705T133000
DTEND;TZID=Europe/Vienna:20240705T143000
DTSTAMP:20260419T065151
CREATED:20240213T191043Z
LAST-MODIFIED:20240701T122643Z
UID:1289-1720186200-1720189800@esmit.eanm.org
SUMMARY:Guidelines for the Use of FDG PET/CT in Infection and Inflammation 2.0
DESCRIPTION:General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection. \n\n\n\nLearning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in infection and inflammation\, based on the updated guidelines for nuclear medicine practice provided by the EANM/SNMMI. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nAndor GlaudemansModeratorGroningen\, Netherlands \n\n\n\n\n\n\n\n\n\n\n\nOlivier GheysensSpeakerBrussels\, Belgium \n\n\n\n\n\nGad AbikhzerSpeakerMontreal\, Canada \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/guidelines-for-the-use-of-fdg-pet-ct-in-infection-and-inflammation-2-0/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240614T133000
DTEND;TZID=Europe/Vienna:20240614T143000
DTSTAMP:20260419T065151
CREATED:20240213T190705Z
LAST-MODIFIED:20240611T073044Z
UID:1285-1718371800-1718375400@esmit.eanm.org
SUMMARY:Cardiovascular PET-CT and PET-MR Imaging
DESCRIPTION:Patients workflows and acquisition protocols in PET/CT and PET/MR with different radiotracers for cardiovascular nuclear medicine imaging. \n\n\n\nLearning Objectives: To learn how to manage radioactive generators 82Sr/82Rb and to acquire cardiovascular imaging in PET/CT or PET/MR and other acquisition protocols. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nPaolo TurcoModeratorPadua\, Italy \n\n\n\n\n\nStephan NekollaModeratorMunich\, Germany \n\n\n\n\n\n\nSylvia SchachoffSpeakerMunich\, Germany \n\n\n\nIan ArmstrongSpeakerManchester\, UK \n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiovascular-pet-ct-and-pet-mr-imaging/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240607T133000
DTEND;TZID=Europe/Vienna:20240607T143000
DTSTAMP:20260419T065151
CREATED:20240213T190217Z
LAST-MODIFIED:20240528T080732Z
UID:1282-1717767000-1717770600@esmit.eanm.org
SUMMARY:CT Optimization in Hybrid Imaging
DESCRIPTION:Hybrid Imaging\, SPECT/CT and PET/CT encompasses not only the well-known nuclear medicine cameras (Single Photon Emission Computed Tomography\, SPECT and Positron Emission Tomography\, PET) but also the CT-camera (Computed Tomography\, CT)\, which can be used as a device to determine the attenuation of the radiation emitted from the radiopharmaceutical within the patient making it possible to perform a thorough attenuation correction\, and to localise the radiation sources within the patient. Using the CT for this purpose\, the radiation dose can be kept at a lower level. There is however also the possibility to use the CT for diagnostic purposes\, resulting in radiological images with considerably increased image quality. Using the CT also for diagnostic purposes will add significantly to the radiation dose of the patient. The justification and optimization process of the CT-imaging is always important but especially when using the CT also for diagnostic purpose. This webinar will focus on the optimization process of Hybrid Imaging with special attention to the CT. \n\n\n\nLearning Objectives: The aim of this webinar is to highlight the optimization process of the CT in order to avoid unecessary radiation dose to the patient. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSigrid Leide SvegbornModeratorMalmö\, Sweden \n\n\n\n\n\nKristina YdströmSpeakerLund\, Sweden \n\n\n\n\n\nElena Prieto AzcarateSpeakerNavarra\, Spain \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/ct-optimization-in-hybrid-imaging/
CATEGORIES:Instrumentation, Technology, Science,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240419T133000
DTEND;TZID=Europe/Vienna:20240419T143000
DTSTAMP:20260419T065151
CREATED:20240213T185845Z
LAST-MODIFIED:20240409T141814Z
UID:1280-1713533400-1713537000@esmit.eanm.org
SUMMARY:Exploiting Radiobiological Effects of Targeted Radionuclide Therapy
DESCRIPTION:Radiobiology is a branch of biology devoted to the study of biological effects of ionizing radiation on living organisms: we can speak about radiobiology in different clinical and research settings of Nuclear Medicine: dosimetry\, preclinical and translational science\, oncology\, theranostics. With this webinar we will try to better understand the importance of this topic regarding targeted radionuclide therapy\, in particular we will start from the questions from a clinician’s side with a great experience in PRRT and we will move towards the possible answers from experts in dosimetry and radiobiology.  \n\n\n\nRadiobiology is fundamental to better understand some mechanisms of response to therapies and also in order to reach the most important target: we always need more efficient and safer radiopharmaceuticals for personalized cancer diagnosis and treatment. \n\n\n\nLearning Objectives: The aim of this course is to understand the importance of radiobiology in radionuclide therapy. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nChiara Maria GranaModeratorMilan\, Italy \n\n\n\n\n\nLisa BodeiSpeakerNew York\, USA \n\n\n\n\n\n\nCaroline StokkeSpeakerOslo\, Norway \n\n\n\nJean-Pierre PougetSpeakerMontpellier\, France \n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/exploiting-radiobiological-effects-of-targeted-radionuclide-therapy/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240412T133000
DTEND;TZID=Europe/Vienna:20240412T143000
DTSTAMP:20260419T065151
CREATED:20240213T185351Z
LAST-MODIFIED:20240402T110609Z
UID:1255-1712928600-1712932200@esmit.eanm.org
SUMMARY:Basic GMP and the Challenges of Annex 1: Manufacture of Sterile Products
DESCRIPTION:This webinar will give an introduction into the GMP rules\, basics and application to radiopharmaceutical productions. \n\n\n\nLearning Objectives: The aim of the webinar is to deliver the basic of GMP applied to radiopharmaceutical production. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nHendrikus BoersmaSpeakerHospital Pharmacist/ Clinical Pharmacologist\, QP\, Section Co-ordinator Radiochemistry and Radiopharmacy\, Assistant Professor\, Hospital Pharmacist for Radiopharmacy and Clinical Trials support\, Department of Clinical Pharmacy and Pharmacology UMCG AP50\, Department of Nuclear Medicine and Molecular Imaging\, University Medical Center Groningen\, Netherlands \n\n\n\n\n\nNeil HartmanSpeakerHead of Nuclear Medicine\, Swansea Bay University Health Board\, Singleton Hospital\, Swansea\, United Kingdom \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/basic-gmp-and-the-challenges-of-annex-1-manufacture-of-sterile-products/
CATEGORIES:Live Webinars,Radiopharmaceuticals
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240301T133000
DTEND;TZID=Europe/Vienna:20240301T143000
DTSTAMP:20260419T065151
CREATED:20240213T184142Z
LAST-MODIFIED:20240226T143243Z
UID:1253-1709299800-1709303400@esmit.eanm.org
SUMMARY:Full Quantification for Brain Imaging
DESCRIPTION:The webinar will refresh the basics of full quantification and kinetics in nuclear neurology. Then some insights into new technologies and quantification will be given to the attendees. \n\n\n\nLearning Objectives: To improve the knowledge on the topic of full quantification in neurology and give the NM specialist the tools to think critically about the results. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nAdriaan LammertsmaSpeakerGroningen\, Netherlands \n\n\n\n\n\nRonald BoellaardModeratorAmsterdam\, Netherlands \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/full-quantification-for-brain-imaging/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240209T133000
DTEND;TZID=Europe/Vienna:20240209T143000
DTSTAMP:20260419T065151
CREATED:20240220T172054Z
LAST-MODIFIED:20240220T172055Z
UID:1465-1707485400-1707489000@esmit.eanm.org
SUMMARY:Cardiac Hybrid Imaging
DESCRIPTION:This webinar will provide knowledge about hybrid imaging SPECT/ CT and PET/CT: CT acquisition protocol\, added value of CACS and incidental findings on CTAC. \n\n\n\n \n\n\n\nLearning Objectives: The aim of the webinar is to: \n\n\n\n\nKnow about the indications for hybrid imaging in CAD \n\n\n\nDiscuss advantages and challenges \n\n\n\nGet to know the protocols \n\n\n\nKnow how to set up a hybrid imaging in your department\n\n\n\n\n\n\n\n\nWatch the recording in our Video LibraryEnter the eLearning store to register for the Annual Access Plan FOR FREE. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nFabien HyafilModeratorParis\, France \n\n\n\n\n\n\n\n\n\n\n\nFederico CaobelliSpeakerBern\, Switzerland \n\n\n\n\n\nRonny BuechelSpeakerZurich\, Switzerland \n\n\n\n\n\nAntti SarasteSpeakerTurku\, Finland \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiac-hybrid-imaging/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240202T133000
DTEND;TZID=Europe/Vienna:20240202T143000
DTSTAMP:20260419T065151
CREATED:20240220T171246Z
LAST-MODIFIED:20240220T171247Z
UID:1461-1706880600-1706884200@esmit.eanm.org
SUMMARY:Diagnostic and Therapy of Medullary Thyroid Cancer
DESCRIPTION:This webinar will provide the evidence for PET imaging in medullary thyroid cancer according to the literature and the to international recommendations with a focus on the available radiopharmaceuticals and perspectives. \n\n\n\nLearning Objectives: The aim of this webinar is to understand and to learn the correct use of PET radiopharmaceuticals for staging and restaging medullary thyroid cancer. \n\n\n\n\n\n\n\nWatch the recording in our Video LibraryEnter the eLearning store to register for the Annual Access Plan FOR FREE. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDesiree DeandreisModeratorGustave Roussy – Villejuif\, France \n\n\n\n\n\n\n\n\n\n\n\nLuca GiovanellaSpeakerUniversity of Zürich – Zurich\, Switzerland \n\n\n\n\n\nJulien HadouxSpeakerENDOCAN-TUTHYREF network – Villejuif\, France \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/diagnostic-and-therapy-of-medullary-thyroid-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
END:VCALENDAR